Clinical Trials
4
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- Conditions
- Burns
- Interventions
- Drug: Investigational Drug, MW-III
- First Posted Date
- 2011-02-16
- Last Posted Date
- 2025-06-03
- Lead Sponsor
- Skingenix, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT01297400
- Locations
- 🇺🇸
University of Iowa Health Care, Iowa City, Iowa, United States
🇺🇸Valleywise Health Medical Center, Phoenix, Arizona, United States
🇺🇸University of CA Davis Medical Center, Sacramento, California, United States
A Clinical Study of the Safety and Efficacy of MEBO® Wound Ointment in Subjects With Diabetic Foot Ulcers (Pilot)
- Conditions
- Diabetic Foot Ulcers
- Interventions
- Drug: MEBO Wound OintmentProcedure: Standard of Care (sterile saline moistened gauze)
- First Posted Date
- 2010-06-30
- Last Posted Date
- 2019-04-26
- Lead Sponsor
- Skingenix, Inc.
- Target Recruit Count
- 7
- Registration Number
- NCT01154374
- Locations
- 🇺🇸
Blume Podiatry Group, P.C., New Haven, Connecticut, United States
🇺🇸Boston University School of Medicine, Boston, Massachusetts, United States
A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Venous Leg Ulcers
- Conditions
- Ulcers
- Interventions
- Drug: MEBO Wound Ointment (MEBO)Procedure: Standard of Care
- First Posted Date
- 2010-06-07
- Last Posted Date
- 2019-04-26
- Lead Sponsor
- Skingenix, Inc.
- Target Recruit Count
- 5
- Registration Number
- NCT01138436
- Locations
- 🇺🇸
Center for Clinical Research, Inc., Castro Valley, California, United States
🇺🇸University of Miami Miller School of Medicine, Miami, Florida, United States
A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot Ulcers
- Conditions
- Diabetic Foot Ulcers
- Interventions
- Drug: MEBO Wound Ointment (MEBO)Other: Standard of Care
- First Posted Date
- 2010-02-18
- Last Posted Date
- 2019-04-26
- Lead Sponsor
- Skingenix, Inc.
- Target Recruit Count
- 75
- Registration Number
- NCT01070433
- Locations
- 🇺🇸
HOPE Research Institute, Phoenix, Arizona, United States
🇺🇸Center for Clinical Research, Inc., Castro Valley, California, United States
🇺🇸ILD Consulting, Inc., Encinitas, California, United States